Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Article
Nature 449, 862-866 (18 October 2007) | doi:10.1038/nature06187;
Open Innovation Challenges
-
Novel Approaches to Protecting Maize from Insect Damage
The Seeker is looking for novel approaches to protecting maize from insect damage. This Challenge re...
-
Optimizing Sub-cellular Localization Tags
The Seeker is looking for methods to optimize sub-cellular localization tags for protein expression....
nature jobs
Postdoctoral Research Associate
- Rice University
- Houston, Texas, USA
Research Scientist – Ecology of Phytoplankton and Primary Producers (Experimental Lakes Area)
- Fisheries and Oceans Canada (DFO)
- Winnipeg, Manitoba, Canada
Helicobacter exploits integrin for type IV secretion and kinase activation
Integrins are important mammalian receptors involved in normal cellular functions as well as pathogenesis of chronic inflammation and cancer. We propose that integrins are exploited by the gastric pathogen and type-1 carcinogen Helicobacter pylori for injection of the bacterial oncoprotein cytotoxin-associated gene A (CagA) into gastric epithelial cells. Virulent H. pylori express a type-IV secretion pilus that injects CagA into the host cell; CagA then becomes tyrosine-phosphorylated by Src family kinases. However, the identity of the host cell receptor involved in this process has remained unknown. Here we show that the H. pylori CagL protein is a specialized adhesin that is targeted to the pilus surface, where it binds to and activates integrin |[agr]|5|[bgr]|1 receptor on gastric epithelial cells through an arginine-glycine-aspartate motif. This interaction triggers CagA delivery into target cells as well as activation of focal adhesion kinase and Src. Our findings provide insights into the role of integrins in H.-pylori-induced pathogenesis. CagL may be exploited as a new molecular tool for our further understanding of integrin signalling.
&
Abstract
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).

